Vertiv Holdings CEO Albertazzi to Present at November Investor Conference
Vertiv Holdings executives are scheduled to attend an investor conference in November, providing an opportunity for leadership to engage with the financial…
Stocks: the latest market news with AI summary, sentiment and the assets affected, updated around the clock.
Vertiv Holdings executives are scheduled to attend an investor conference in November, providing an opportunity for leadership to engage with the financial…
Oracle is upgrading its Marketplace platform with new purchasing options and seller collaboration tools to boost cloud revenue and partner ecosystem growth.
Dayforce expands its AI-driven recruiting suite through the acquisition of Ribbon AI, focusing on automated voice and video screening tools to streamline…
Doxa AB shareholders have approved a name change to Nordvi Sverige AB, a major capital reduction, and new board authorization for share…
Koppers Holdings Inc. (NYSE: KOP) announced the scheduling of its third quarter 2026 earnings conference call, marking a routine update for the…
Intelligent Protection Management Corp. triggers bearish sentiment as it files for unregistered equity sales, signaling a potential dilution of existing shareholder value.
Individual investors frequently exhaust brokerage accounts within 12 months, struggling to compete against institutional pros who dominate intraday market dynamics through superior…
Sinexcel secures international cybersecurity certification, bolstering its credibility as a provider of critical power infrastructure for AI-driven data centers.
S-Bank's voluntary cash tender offer for Oma Savings Bank has reached 97.32% acceptance, paving the way for full control and potential delisting…
Superteam Wheels enters the premium cycling market with the launch of its MATIC sub-brand and the debut of the flagship S68 one-piece…
SAFE Structure Designs collaborates with Johnny Buscema to advance prosthetic assistance programs in Clearwater, Florida, focusing on community-driven service and faith-based outreach.
Alebund Pharmaceuticals and partner R1 Therapeutics have detailed the Phase IIb trial design for AP306, marking a key procedural milestone in the…